Skeletal muscle dysfunction in COPD;Disfunción muscular esquelética en la EPOC

Archivos de Bronconeumologia

Volumn 45, Issue SUPPL.5, 2009, Pages 36-41

  Gea, Joaquim ^a   Martínez Llorens, Juana ^a   Ausín, Pilar ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

COPD; Muscles of the extremities; Muscular dysfunction; Rehabilitation; Ventilatory muscles

Indexed keywords

ARTICLE; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE SEVERITY; HUMAN; HYPOXIA; LEG MUSCLE; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE TRAINING; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PHENOTYPE; PROGNOSIS; SYMPTOMATOLOGY;

HUMANS; MUSCLE, SKELETAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUSCLES;

EID: 72149110123     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S0300-2896(09)72862-5     Document Type: Article

References (60)

1. Swallow E.B., Reyes D., Hopkinson N.S., Man W.D., Porcher R., Cetti E.J., et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 62 (2007) 115-120
2. Epstein S.K. An Overview on Respiratory Muscle Function. Clin Chest Med 15 (1994) 619-639
3. Gea J., and Barreiro E. Actualización en los mecanismos de disfunción muscular en la EPOC. Arch Bronconeumol 44 (2008) 328-337
4. Hamilton A.L., Killian K.J., Summers E., and Jones N.L. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 52 (1995) 2021-2031
5. American Thoracic Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 159 (1999) S1-S40
6. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. National Heart, Lung and Blood Institute. Update of the Management Sections, GOLD website. [Acceso diciembre 2008.] Disponible en: www.goldcopd.com
7. Gea J., Barreiro E., and Orozco-Levi M. Skeletal muscle adaptation to disease states. In: Bottinelli R., and Reggiani C. (Eds). Skeletal Muscle Plasticity in Health and Disease: From genes to whole muscle (2006), Springer, Doordrecht The Netherlands 315-360
8. Goldman M.D., Grassino A., Mead J., and Sears A. Mechanics of the human diaphragm during voluntary contraction: Dynamics. J Appl Physiol 44 (1978) 840-848
9. Similowsky Th., Yan S., Gaithier A.P., and Macklem P.T. Contractile properties of the human diaphragm during chronic hyperinflation. N Eng J Med 325 (1991) 917-923
10. Zhu E., Petroff B., Gea J., Comtois N., and Grassino A. Diaphragm muscle injury after inspiratory resistive breathing. Am J Respir Crit Care Med 155 (1997) 1110-1116
11. Orozco-Levi M., Lloreta J., Minguella J., Serrano S., Broquetas J., and Gea J. Injury of the human diaphragm associated with exertion and COPD. Am J Respir Crit Care Med 164 (2001) 1734-1739
12. Levine S., Kaiser L., Leferovich J., and Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 337 (1997) 1799-1806
13. Orozco-Levi M., Gea J., Lloreta J., Felez M., Minguella J., Serrano S., et al. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 13 (1999) 371-378
14. Levine S., Nguyen T., Friscia M., Zhu J., Szeto W., Kucharczuk J.C., et al. Parasternal intercostal muscle remodeling in severe chronic obstructive pulmonary disease. J Appl Physiol 101 (2006) 1297-1302
15. Campbell J.A., Hughes R.L., Shagal V., Frederiksen J., and Shields T.W. Alterations in intercostal muscle morphology and biochemistry in patients with chronic obstructive lung disease. Am Rev Respir Dis 122 (1980) 679-686
16. Orozco-Levi M., Gea J., Sauleda J., Corominas J.M., Minguella J., Arán X., et al. Structure of the latissimus dorsi muscle and respiratory function. J Apply Physiol 78 (1995) 1132-1139
17. Sato Y., Asoh T., Honda Y., Fujimatso Y., Higuchi I., and Oizumi K. Morphologic and histochemical evaluation of biceps muscle in patients with chronic pulmonary emphysema manifesting generalized emaciation. Eur Neurol 37 (1997) 116-121
18. Ramirez-Sarmiento A., Orozco-Levi M., Barreiro E., Mendez R., Ferrer A., Broquetas J., et al. Expiratory muscle endurance in chronic obstructive pulmonary disease. Thorax 57 (2002) 132-136
19. Barreiro E., Ferrer A., Hernández-Frutos N., Palacio J., Broquetas J., and Gea J. Expiratory function and cellular properties of the external oblique muscle in patients with extremely severe COPD. Am J Crit Care Med 159 Suppl (1999) A588
20. Bernard S., LeBlanc P., Whittom F., Carrier G., Jobin J., Belleau R., et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158 (1998) 629-634
21. Killian K.J., Leblanc P., Martin D.H., Summers E., Jones N.L., and Campbell E.JM. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow obstruction. Am Rev Respir Dis 146 (1992) 935-940
22. Coronell C., Orozco-Levi M., Mendez R., Ramirez A., Galdiz J.B., and Gea J. Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J 24 (2004) 129-136
23. Ng T.P., Niti M., Fones C., Yap K.B., and Tan W.C. Co-morbid association of depression and COPD: A population-based study. Respir Med 103 (2009) 895-901
24. Jakobsson P., Jorfeldt L., and Brundin A. Skeletal muscle metabolites and fiber types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 3 (1990) 192-196
25. Jakobsson P., Jordfelt L., and Henriksson. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 151 (1995) 374-377
26. Simard C., Maltais F., Leblanc P., Simard P.M., and Jobin J. Mitochondrial and capillarity changes in vastus lateralis muscle of COPD patients: electron microscopy study. Med Sci Sports Exerc 28 (1996) S95
27. Satta A., Migliori G.B., Spanevello A., Neri M., Bottinelli R., Canepari M., et al. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 10 (1997) 2853-2860
28. Whittom F., Jobin J., Simard P.M., LeBlanc P., Simard C., Bernard S., et al. Histochemical and morphological characteristics of the vastus lateralis muscle in COPD patients. Med Sci Sports Exerc 30 (1998) 1467-1474
29. Diffee G.M., Caiozzo V.J., Herrick R.E., and Baldwin K.M. Contractile and biochemical properties of rat soleus and plantaris after hindlimb suspension. Am J Physiol 260 (1991) C528-C534 Cell Physiol 29
30. Bloomfield S.A. Changes in musculoskeletal structure and function with prolonged bed rest. Med Sci Sports Exerc 29 (1997) 197-206
31. Sala E., Roca J., Marrades R.M., Alonso J., Gonzalez de Suso J.M., Moreno A., et al. Effect of endurance training on skeletal muscle bioenergetic in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159 (1999) 1726-1734
32. Hernandez N., Orozco-Levi M., Belalcazar V., Pasto M., Minguella J., Broquetas J.M., et al. Dual morphometrical changes of the deltoid muscle in patients with COPD. Respir Physiol Neurobiol 134 (2003) 219-229
33. Gea J., Pasto M., Carmona M., Orozco-Levi M., Palomeque J., and Broquetas J. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J 17 (2001) 939-945
34. Gea J., Orozco-Levi M., Barreiro E., Ferrer A., and Broquetas J. Structural and functional changes in the skeletal muscles of COPD patients: The "Compartments" Theory. Mon Arch Chest Dis 56 (2001) 214-224
35. Gan W.Q., Man W.Q., Senthilselvan A., and Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59 (2004) 574-580
36. Di Francia M., Barbier D., Mege J.L., and Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150 (1994) 1453-1455
37. Casadevall C., Coronell C., Ramírez-Sarmiento A.L., Martínez-Llorens J., Barreiro E., Orozco-Levi M., et al. Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients. Eur Respir J 30 (2007) 701-707
38. Montes de Oca M., Torres S.H., De Sanctis J., Mata A., Hernández N., and Tálamo C. Skeletal muscle inflammation and nitric oxide in patients with COPD. Eur Respir J 26 (2005) 390-397
39. Flores E.A., Bristain B.R., Pomposelli J.J., Dinarello C.A., Blackburn G.L., and Istfan N.W. Infusion of tumor necrosis factor /cachectin promotes muscle metabolism in the rat. J Clin Invest 83 (1989) 1614-1622
40. Barreiro E., Schols A.M., Polkey M.I., Galdiz J.B., Gosker H.R., Swallow E.B., et al., ENIGMA in COPD project. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 63 (2008) 100-107
41. Jackson M.J., and O'Farrel S. Free radicals and muscle damage. Br Med Bull 49 (1993) 630-641
42. Barreiro E., Gea J., Corominas J.M., and Hussain S.N. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 29 (2003) 771-778
43. Barreiro E., Gea J., Matar G., and Hussain S.N. Expression and carbonylation of creatine kinase in the quadriceps femoris muscles of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 33 (2005) 636-642
44. Barreiro E., De la Puente B., Minguella J., Corominas J.M., Serrano S., Hussain S., et al. Oxidative stress and respiratory muscle dysfunction in severe COPD. Am J Respir Crit Care Med 171 (2005) 1116-1124
45. Vermeeren M.A., Creutzberg E.C., Schols A.M., Postma D.S., Pieters W.R., Roldaan A.C., et al., COSMIC Study Group. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 100 (2006) 1349-1355
46. Schols A., Creutzberg E., Buurman W., Campfield L., Saris W., and Wouters E. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) 1220-1226
47. Schols A., Buurman W., Van den Brekel S., Dentener M.A., and Wouters E.F. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 51 (1996) 819-824
48. Coronell C., Orozco-Levi M., Ramírez-Sarmiento A., Martínez-Llorens J., Broquetas J., and Gea J. Síndrome de bajo peso asociado a la EPOC en nuestro medio. Arch Bronconeumol 38 (2002) 580-584
49. Maltais F., Leblanc P., Simard C., Jobin J., Berubé C., Bruneau J., et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154 (1996) 442-447
50. Lacasse Y., Martin S., Lasserson T.J., and Goldstein R.S. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys 43 (2007) 475-485
51. Lacasse Y., Goldstein R., Lasserson T.J., and Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 18 (2006) CD003793
52. Ramirez-Sarmiento A., Orozco-Levi M., Guell R., Barreiro E., Hernandez N., Mota S., et al. Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am J Respir Crit Care Med 166 (2002) 1491-1497
53. Schols A. Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease. Proc Nutr Soc 62 (2003) 783-791
54. Pasini E., Aquilani R., Dioguardi F.S., D'Antona G., Gheorghiade M., and Taegtmeyer H. Hypercatabolic syndrome: molecular basis and effects of nutritional supplements with amino acids. Am J Cardiol 101 (2008) 11E-15E
55. Slinde F., Grönberg A.M., Engström C.R., Rossander-Hulthén L., and Larsson S. Individual dietary intervention in patients with COPD during multidisciplinary rehabilitation. Respir Med 96 (2002) 330-336
56. Casaburi R. Anabolic therapies in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 53 (1998) 454-459
57. Burdet L., De Muralt B., Schutz Y., Pichard C., and Fitting J.W. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med 156 (1997) 1800-1806
58. De Boer W.I., Yao H., and Rahman I. Future therapeutic treatment of COPD: struggle between oxidants and cytokines. Int J Chron Obstruct Pulmon Dis 2 (2007) 205-228
59. Koechlin C., Couillard A., Simar D., Cristol J.P., Bellet H., Hayot M., et al. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?. Am J Respir Crit Care Med 169 (2004) 1022-1027
60. Barreiro E., Gáldiz J.B., Mariñán M., Álvarez F.J., Hussain S.N., and Gea J. Respiratory loading intensity and diaphragm oxidative stress: N-acetylcysteine effects. J Appl Physiol 100 (2006) 555-563